Drug intelligence / Profile preview

Zenvit Gold

Development stage: Unknown
Lead developer: Kaizen Pharmaceuticals
Modality: Small Molecules
Administration: Oral

Overview

Zenvit Gold is a nutritional supplement manufactured by Kaizen Pharmaceuticals. It is a soft gelatin capsule formulation containing a combination of Omega-3 fatty acids (500mg), Lutein (10mg), Zeaxanthin (2mg), and Astaxanthin (2mg). Classified as a multivitamin and adjuvant therapy, it is used as a general nutrient supplement to support overall health, particularly ocular health and antioxidant status. As a finished generic formulation, it provides essential nutrients rather than acting as an investigational drug with a specific biological target.

Brand names: Zenvit Gold

Beyond the preview

Go deeper on Zenvit Gold.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zenvit Gold.

Explore the full profile